SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-225621
Filing Date
2019-08-21
Accepted
2019-08-21 08:02:02
Documents
3
Period of Report
2019-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793938d8k.htm 8-K 31027
2 EX-99.1 d793938dex991.htm EX-99.1 8816
3 GRAPHIC g793938g0529090536334.jpg GRAPHIC 2425
  Complete submission text file 0001193125-19-225621.txt   44692
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 191041247
SIC: 2834 Pharmaceutical Preparations